your market intelligence analyst
Search Results
312 results
Your search is now limited to «Merck» expert search. 10/11/2019 07:38
Merck announced it has acquired FloDesign Sonics, of Wilbraham, Massachusetts, USA, developer of a unique acoustic cell processing platform for the industrialization of cell and gene therapy manufacturing.
More from
Korean Biomedical Review 10/11/2019 05:15
The agreement is part of Merck's global healthcare corporate strategy to become a specialty innovator as it focuses its capabilities on specialty care through innovative products in the future," Merck Biopharma Korea said.
More from Korean Biomedical Review:
FiercePharmaManufacturing 10/10/2019 15:03
At the event, the Merck CEO also touched on a recent Gallup poll that found pharma ranks dead last among 25 industries in consumer sentiment.
More from FiercePharmaManufacturing:
NASDAQ 10/10/2019 09:54
Merck Stock Has Beaten Its Rivals This Year.
More from NASDAQ:
FierceBiotech 10/10/2019 09:37
Merck taps 4D pharma for bacterial vaccine R&D project Merck has teamed up with 4D pharma to develop bacterial strains as vaccines.
More from FierceBiotech:
ENDPOINTS 10/08/2019 10:57
Merck has signed a research deal with 4D Pharma to use its MicroRX platform to turn living bacteria into vaccines.
More from ENDPOINTS:
Business Wire 10/08/2019 08:00
About Merck For more than a century, Merck, a leading global biopharmaceutical company known as MSD outside of the United States and Canada, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases ...
More from Business Wire: (EU) 10/08/2019 07:22
Merck announced the closing of the transaction to acquire Versum Materials, Inc. for approximately € 5.8 billion.
More from (EU): 10/07/2019 08:49
Merck KGaA completes acquisition of Versum Materials.
More from
Merck Foundation also announced Call for Application for 'Merck More than a Mother” ‘Media Recognition Awards’ for Lesotho and rest of Africa.
More from Middle East North Africa Financial Network (MENAFN):
Merck has the industry’s largest immuno-oncology clinical research program.
More from Pharmaceutical Business Review:

Therapeutic Areas

Clinical Trials and Phases

Business Issues

Companies - Public

Companies - Venture Funded

Financial Results

Global Markets

Global Risk Factors

Government Agencies

Job Titles

Legal and Regulatory

Cell Receptors


Diagnostics and Therapeutics


Drugs - Brand Names

Drugs - Generic



Health Care

Health and Wellness

Human Anatomy

Mechanisms of Action

Medical Devices



Strategic Scenarios



On this page, you see the results of the search you have run.  You may also view the following:

  •  Click on this drop-down menu on the right hand side of the page, to choose between the machine learning-produced Insights Reports, or the listing of concepts extracted from the results, in chart or list format. 

  •  View the number of search results returned for the search in each of your collections, and click on any of those numbers to view the entire listing of results from the chosen collection.

  •  Use the search adjustment drop-downs to change the scope, sorting, and presentation of your results.

  •  Show or hide the record’s caption (content description).

  •  Show actions that can be made with the search result record.

  •  Click on the Save button after running your search, to save it so that its results will be updated each time relevant new content is added to the designated collection. You may choose to be notified via search alerts.

Click here for more info on Search Results

Click here for more info on Machine Learning applications